Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 5, 2010, Pages 2322-2328

  Gillies, Mark C ^a   McAllister, Ian L ^b   Zhu, Meidong ^a   Wong, Wanling ^c   Louis, Damien ^d   Arnold, Jennifer J ^e   Wong, Tien Y ^c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Marsden Eye Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; KENACORT 40; PLACEBO; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; GLUCOCORTICOID;

AGED; ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; EPIRETINAL MEMBRANE; FEMALE; GLAUCOMA; HUMAN; HYPOPYON; INTRAOCULAR HYPERTENSION; LASER COAGULATION; LENS DISEASE; MAJOR CLINICAL STUDY; MALE; PANOPHTHALMITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; RETINA MACULA LUTEA; TREATMENT OUTCOME; VISUAL ACUITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC RETINOPATHY; INJECTION; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RETINA MACULA EDEMA; VITREOUS BODY;

AGED; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 77952489006     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4400     Document Type: Article

References (24)

1. Sutter FK, Simpson JM, Gillies MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: threemonth efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology. 2004;111:2044-2049.
2. Kuppermann BD, Blumenkranz MS, Haller JA, et al. Dexamethasone DDS Phase II Study Group. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007;125:309-317.
3. Cunningham ET Jr, Adamis AP, Altaweel M, et al. Macugen Diabetic Retinopathy Study Group. A phase II randomized doublemasked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology. 2005; 112:1747-1757.
4. Chun DW, Heier JS, Topping TM, et al. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology. 2006;113:1706-1712.
5. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, et al. Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month followup. Ophthalmology. 2007;114:743-750.
6. Diabetic Retinopathy Clinical Research Network Ophthalmology. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115:1447-1449.
7. Gillies MC, Sutter FK, Simpson JM, et al. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a doublemasked, placebo-controlled, randomized clinical trial. Ophthalmology. 2006;113:1533-1538.
8. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298:902-916.
9. Kang SW, Sa HS, Cho HY, et al. Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema. Arch Ophthalmol. 2006;124:653-658.
10. Lam DS, Chan CK, Mohamed S, et al. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Ophthalmology. 2007;114:2162-2167.
11. Age-Related Eye Disease Study Research Group. The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. Am J Ophthalmol. 2001;131: 167-175.
12. Tunc M, Onder HI, Kaya M. Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema. Ophthalmology. 2005;112:1086-1091.
13. Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol. 2005;140:695-702.
14. Larsson J, Zhu M, Sutter F, Gillies MC. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol. 2005; 139:802-806.
15. Wallow IH. Repair of the pigment epithelial barrier following photocoagulation. Arch Ophthalmol. 1984;102:126-135.
16. Wilson DJ, Finkelstein D, Quigley HA, Green WR. Macular grid photocoagulation: an experimental study on the primate retina. Arch Ophthalmol. 1988;106:100-105.
17. Landers MB 3rd, Stefansson E, Wolbarsht ML. Panretinal photocoagulation and retinal oxygenation. Retina. 1982;2:167-175.
18. Pournaras CJ, Tsacopoulos M, Strommer K, et al. Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology. 1990;97: 1329-1333.
19. Gottfredsdóttir MS, Stefánsson E, Jónasson F, Gíslason I. Retinal vasoconstriction after laser treatment for diabetic macular edema. Am J Ophthalmol. 1993;115:64-67.
20. Luttrull1 JK, Musch DC Mainster MA. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol. 2005;89:74-80.
21. Figueira J, Khan J, Nunes S, et al. Prospective randomized controlled trial comparing subthreshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol. 2009;93(10):1341-1344.
22. Marshall J, Clover G, Rothery S. Some new findings on retinal irradiation by krypton and argon lasers. Doc Ophthalmol Proc Ser. 1984;36:21-37.
23. Wilson AS, Hobbs BG, Shen WY, et al. Argon laser photocoagulation-induced modification of gene expression in the retina. Invest Ophthalmol Vis Sci. 2003;44:1426-1434.
24. Sutter KP, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone: a case series. Br J Ophthalmol. 2003; 87:972-974.